A
Adaptive Biotechnologies
Seattle, United States
Founded 2009 NASDAQ: ADPT
About
Biotechnology company developing immune-driven medicine through sequencing
Company Details
- Type
- public
- Employees
- 600+
- Funding
- Public
Key Products
- clonoSEQ
- immunoSEQ
- T-Detect